<DOC>
	<DOCNO>NCT02104544</DOCNO>
	<brief_summary>This multi-center , cross-sectional , non-interventional , observational study——an investigation carry 816 pregnant ( pregnant week 17±2 group pregnant week 39±2 group ; 408 case group ) 408 lactate woman ( post-natal lactation day 42±7 group ) total 4 site 3 typical area ( 1 coastal region , 2 inland region 1 lake region ) China study correlation DHA intake DHA concentration blood breast milk .</brief_summary>
	<brief_title>Investigation DHA Intake Pregnant Lactating Women China</brief_title>
	<detailed_description>This multi-center , cross-sectional , non-interventional , observational study 816 pregnant ( gestation week 17±2 group gestation week 39±2 group 408 case group ) 408 lactate woman ( post-natal lactation day 42±7 group ) total 4 site 3 typical area ( 1 coastal region , 2 inland region 1 lake region ) China study correlation DHA intake DHA concentration blood breast milk . Investigators mainly physicians major gynaecology obstetrics , etc . During visit , study physician record patient 's social demographic data , disease relevant medication history , review medical record , assess DHA intake DHA Screener , determine DHA concentration erythrocyte membrane , plasma breast milk , validate feasibility DHA Screener DHA intake assessment tool determine DHA concentration body . Subjects meet inclusion criterion non exclusion criterion inform relevant information study . Subjects voluntarily consent participate study sign inform consent form . Screening study schedule long 5 month . In study , additional examination intervention require .</detailed_description>
	<mesh_term>Nutrition Disorders</mesh_term>
	<criteria>PREGNANT WOMEN : Healthy woman present week 17±2 week 39±2 obstetric examination ; 1840 year age ; Monocyesis ; Having sign informed consent form voluntarity participate study . LACTATING WOMEN : Healthy woman present day 42±7 postnatal visit ; 1840 year age ; Monocyesis ; Having sign informed consent form voluntarily participate study Administration DHA supplement ( milk powder pregnant woman , DHA soft capsule , Zmarto , NURIZ , Naturies , HeadDHA , Beibeicong , Nutrimed etc ) ; Still experience severe vomit 16 week pregnancy ; Women heart , liver , kidney , ( ALT AST≥ 1.5 time normal upper limit , Cr &gt; normal upper limit ) severe lung disease laboratory abnormality ( i.e.lipid metabolism disorder ) may interfere interpretation study result , indicate previous examination ; Pregnant woman currently participate clinical trial participate another clinical trial last 30 day ; Women judgement investigator expect comply protocol study procedure .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>DHA intake ;</keyword>
	<keyword>Plasma ;</keyword>
	<keyword>Erythrocyte ;</keyword>
	<keyword>Breast milk .</keyword>
</DOC>